0001209191-17-002317.txt : 20170105 0001209191-17-002317.hdr.sgml : 20170105 20170105181535 ACCESSION NUMBER: 0001209191-17-002317 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170101 FILED AS OF DATE: 20170105 DATE AS OF CHANGE: 20170105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Audentes Therapeutics, Inc. CENTRAL INDEX KEY: 0001628738 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 461606174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 600 CALIFORNIA ST., 17TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94108 BUSINESS PHONE: 415-638-6556 MAIL ADDRESS: STREET 1: 600 CALIFORNIA ST., 17TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Smith Julie CENTRAL INDEX KEY: 0001557928 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37833 FILM NUMBER: 17512241 MAIL ADDRESS: STREET 1: C/O RAPTOR PHARMACEUTICAL CORP STREET 2: 9 COMMERCIAL BLVD, SUITE 200 CITY: NOVATO STATE: CA ZIP: 94949 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-01-01 0 0001628738 Audentes Therapeutics, Inc. BOLD 0001557928 Smith Julie C/O AUDENTES THERAPEUTICS, INC. 600 CALIFORNIA STREET, 17TH FLOOR SAN FRANCISCO CA 94108 1 0 0 0 Stock Option (right to buy) 17.85 2017-01-01 4 A 0 18000 0.00 A 2027-01-01 Common Stock 18000 18000 D The option vests as to 2.777% of the total shares monthly, beginning January 12, 2017, with 100% of the total shares vested and exercisable on December 12, 2019, subject to the reporting person's provision of service to the issuer on each vesting date. /s/ Thomas Soloway as attorney-in-fact for Julie Anne Smith 2017-01-05